Fas Expression in the Context of CD34 Expression
| . | CD34− . | CD34+ . |
|---|---|---|
| Fas ≥20% | 19/21 (90.5%) | 34/43 (79.1%) |
| Fas ≥50% | 14/21 (66.7%) | 19/43 (44.2%) |
| Fas RFI | 1.28-14.66 (4.66) | 1.33-25.27 (4.33) |
| . | CD34− . | CD34+ . |
|---|---|---|
| Fas ≥20% | 19/21 (90.5%) | 34/43 (79.1%) |
| Fas ≥50% | 14/21 (66.7%) | 19/43 (44.2%) |
| Fas RFI | 1.28-14.66 (4.66) | 1.33-25.27 (4.33) |
Among 43 cases with CD34+ leukemia (CD34+, ≥20% leukemia cells were CD34+) 34 expressed Fas in ≥20% of cells and 19 expressed Fas in ≥50% cells. Among 21 CD34− (CD34−) cases, 19 and 14 expressed Fas in ≥20% and 50% of leukemia cells, respectively. Range and median are shown.